Get the Stockscreener App
95.09
0.40%
0.38
After Hours:
95.09
Zimmer Biomet Holdings Inc stock is traded at $95.09, with a volume of 1.48M.
It is up +0.40% in the last 24 hours and down -7.75% over the past month.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
See More
Previous Close:
$94.71
Open:
$94.91
24h Volume:
1.48M
Relative Volume:
1.01
Market Cap:
$18.84B
Revenue:
$7.83B
Net Income/Loss:
$825.20M
P/E Ratio:
23.15
EPS:
4.1067
Net Cash Flow:
$1.05B
1W Performance:
-3.78%
1M Performance:
-7.75%
6M Performance:
-7.09%
1Y Performance:
-8.13%
1-Day Range:
$94.01
$96.33
1-Week Range:
$94.01
$99.86
52-Week Range:
$89.24
$114.72
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Name
Zimmer Biomet Holdings Inc
Sector
Industry
Phone
(574) 267-6131
Address
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
95.09 | 18.76B | 7.83B | 825.20M | 1.05B | 4.1067 |
|
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jul-15-25 | Upgrade | Roth Capital | Neutral → Buy |
| Dec-17-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Peer Perform |
| Jul-01-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-30-24 | Initiated | Goldman | Neutral |
| May-21-24 | Upgrade | Argus | Hold → Buy |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Aug-28-23 | Upgrade | BTIG Research | Neutral → Buy |
| May-03-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-31-23 | Upgrade | Jefferies | Underperform → Hold |
| Mar-29-23 | Initiated | UBS | Sell |
| Mar-10-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-05-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Underweight |
| Oct-12-22 | Initiated | Jefferies | Underperform |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Apr-01-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Underperform |
| Mar-02-22 | Downgrade | Loop Capital | Buy → Hold |
| Feb-08-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-08-22 | Reiterated | Citigroup | Buy |
| Feb-08-22 | Reiterated | Deutsche Bank | Hold |
| Feb-08-22 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-08-22 | Reiterated | JP Morgan | Neutral |
| Feb-08-22 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-08-22 | Reiterated | Stifel | Buy |
| Feb-08-22 | Reiterated | Truist | Buy |
| Feb-08-22 | Reiterated | UBS | Neutral |
| Feb-08-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | UBS | Buy → Neutral |
| Jan-19-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-10-22 | Downgrade | Mizuho | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-09-21 | Downgrade | Needham | Strong Buy → Buy |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Nov-23-21 | Downgrade | Argus | Buy → Hold |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-18-20 | Reiterated | Needham | Strong Buy |
| Oct-20-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Aug-05-20 | Reiterated | Needham | Strong Buy |
| Apr-28-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Apr-07-20 | Reiterated | Needham | Strong Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-07-19 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-18-19 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-12-19 | Upgrade | Argus | Hold → Buy |
| Jul-30-19 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-29-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jun-11-19 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Apr-24-19 | Upgrade | Needham | Buy → Strong Buy |
View All
Zimmer Biomet Holdings Inc Stock (ZBH) Latest News
BTIG Adjusts Price Target on Zimmer Biomet Holdings to $122 From $118, Maintains Buy Rating - MarketScreener
Candlestick signals on Zimmer Biomet Holdings Inc. stock todayTrade Analysis Summary & Smart Money Movement Tracker - newser.com
Market reaction to Zimmer Biomet Holdings Inc.’s recent newsWeekly Trend Recap & AI Driven Stock Movement Reports - newser.com
Will Zimmer Biomet Holdings Inc. see short term momentumMarket Sentiment Report & Free Growth Oriented Trading Recommendations - newser.com
Zimmer Biomet Earnings Preview: What to Expect - Yahoo Finance
BTIG Raises Price Target for Zimmer Biomet Holdings (ZBH) to $12 - GuruFocus
Johnson Investment Counsel Inc. Sells 22,675 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Price momentum metrics for Zimmer Biomet Holdings Inc. explainedLayoff News & Community Consensus Stock Picks - newser.com
Can Zimmer Biomet Holdings Inc. (ZIM) stock sustain institutional flowsChart Signals & Reliable Price Action Trade Plans - newser.com
Matrix Asset Advisors Inc. NY Lowers Stake in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Q3 Earnings To Highlight Innovation And GrowthWhy I Think It's A Buy - Seeking Alpha
Analyzing drawdowns of Zimmer Biomet Holdings Inc. with statistical tools2025 Bull vs Bear & Precise Swing Trade Entry Alerts - newser.com
Costello Asset Management INC Sells 6,560 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. $ZBH Stock Position Raised by Callan Family Office LLC - MarketBeat
Zimmer Biomet Earnings Preview: What To Expect - Barchart.com
RBC Trims Price Target on Zimmer Biomet Holdings to $111 From $115, Keeps Outperform Rating - MarketScreener
Custom watchlist performance reports with Zimmer Biomet Holdings Inc.Market Activity Summary & Community Consensus Stock Picks - newser.com
Zimmer Biomet Holdings, Inc. $ZBH Shares Acquired by Truist Financial Corp - MarketBeat
Zimmer Biomet launches foot, ankle trauma systems - MassDevice
Tag Archives: foot and ankle trauma - InkFreeNews.com
Zimmer Biomet Launches Foot, Ankle Solutions For Complex Trauma Cases - InkFreeNews.com
Is Zimmer Biomet Holdings Inc. stock attractive after correctionAnalyst Upgrade & Low Drawdown Trading Strategies - newser.com
Is Zimmer Biomet Holdings Inc ZIM a good long term investmentStock Price Divergence & Small Investment Portfolio Tips - earlytimes.in
Identifying reversal signals in Zimmer Biomet Holdings Inc.Weekly Trend Report & Safe Capital Growth Stock Tips - newser.com
Janney Montgomery Scott LLC Acquires 9,482 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet's (ZBH) "Hold (C-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Zimmer Biomet Completes Acquisition Of Orthopedic Robotics Company - InkFreeNews.com
Zimmer Biomet closes acquisition of Monogram Technologies - MSN
Zimmer Biomet launches new solutions for complex foot and ankle trauma - Investing.com Canada
Zimmer Biomet And Paragon 28 Launch Two New Foot And Ankle Trauma Solutions - Nasdaq
Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases - PR Newswire
Robeco Institutional Asset Management B.V. Sells 10,504 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Secured Retirement Advisors LLC Invests $413,000 in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Wraps Up Purchase of Orthopedic Robotics Group Monogram Technologies - MarketScreener
Zimmer Biomet completes acquisition of Monogram Technologies to expand orthopedic robotics portfolio - MassDevice
Zimmer Biomet Holdings (ZBH) Completes Merger with Monogram Tech - GuruFocus
Zimmer Biomet Acquires Monogram Orthopaedics on October 7, 2025 - TipRanks
Zimmer Biomet Acquires Monogram Technologies to Enhance Robotics - TipRanks
Evercore ISI Group Lowers Price Target for Zimmer Biomet Holdings (ZBH) | ZBH Stock News - GuruFocus
Zimmer Biomet Holdings, Inc. completed the acquisition of Monogram Technologies Inc.. - MarketScreener
Evercore ISI Cuts Zimmer Biomet (NYSE:ZBH) Price Target to $104.00 - MarketBeat
What analysts say about Zimmer Biomet Holdings Inc ZIM stockPrice-to-Earnings Ratio Insights & Easy Tools to Analyze Your Investment Risk - earlytimes.in
Oct. 7Zimmer Biomet acquires AI-robotics orthopedic company Monogram Technologies - Fort Wayne Business Weekly
Zimmer Biomet (ZBH) Finalizes Acquisition of Monogram Technologies for $177M - GuruFocus
Evercore ISI Adjusts Zimmer Biomet Price Target to $104 From $106, Maintains In Line Rating - MarketScreener
Zimmer Biomet (ZBH) Finalizes Acquisition of Monogram Technologies - GuruFocus
Does Japan’s Approval of Iodine Hip Implants Alter the Bull Case for Zimmer Biomet (ZBH)? - Yahoo Finance
Zimmer Biomet Completes Acquisition of Monogram Technologies - WV News
Zimmer Biomet completes acquisition of Monogram Technologies - Investing.com
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Given Average Rating of "Hold" by Analysts - MarketBeat
Will Japan’s Approval of Iodine Hip Implants Redefine Zimmer Biomet Holdings' (ZBH) Infection Prevention Narrative? - Sahm
Zimmer Biomet Holdings Inc Stock (ZBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.01%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):